Cheryl Scott

1 month ago | bioprocessintl.com | Cheryl Scott |Jason Beckwith |Stephen Goldrick |Chad Hafer

Cheryl Scott, Editor in Chief. In publishing, the general rule of thumb is for magazines to undergo a redesign process every five years or so. Longtime BPI subscribers will know that it’s been more than that for us — although our website has been fully refreshed recently. Perhaps that is a sign of the times, and maybe it has something to do with our relatively stable editorial staff and its comfort level with familiar designs.

1 month ago | bioprocessintl.com | Cheryl Scott

BioProcess International's Editor in Chief, Cheryl Scott, interviews 1st place poster hall winner, Eashwar Rajaraman, principal scientist at Biologics Research Center of Novartis. His team's poster “Iterative design of a DSP Work Package for Multispecifics: Learnings and Adaptations,” summarizes lessons learned in developing a platform-like approach to downstream processing of multispecific molecules.

Mar 6, 2025 | bioprocessintl.com | Cheryl Scott |Olena Chervonenko |Mike King |Philip Johnson

In nearly 30 years of working as an editor covering the biopharmaceutical industry, first with BioPharm and later as cofounder of BioProcess International, I’ve copyedited thousands of articles. From business and regulatory discussions to technical reports and reviews, sponsored “advertorial” pieces, and beyond, I’ve seen it all in relation to the biopharmaceutical industry. Some papers, however, have stuck with me more than others, and one in particular comes to mind often lately.

Dec 12, 2024 | bioprocessintl.com | Cheryl Scott |Dana Cipriano |Brian Gazaille |Derek Ryan

Potency. Stability. Product characterization. Bioassays and other analytical methods provide a foundation of information on which biopharmaceutical development and manufacturing are built. Companies working with proteins, gene therapies, and other biological modalities are increasingly interested in taking a platform approach. They would love to have a set of go-to methods and protocols that can be applied across similar products in their portfolios.

Sep 1, 2024 | bioprocessintl.com | Cheryl Scott |Gigi Bat-Erdene |Jeff Fischer |Brian Gazaille

With the first half of 2024 now in the rearview mirror, I finally feel like I’m getting my feet under me as editor in chief ofBioProcess International. Since the first issue in January 2003, I’ve had the pleasure of helping BPI to establish itself as the leading publication and events brand for the global biopharmaceutical industry. And this September, all the BPI editors will attend our flagship conference and exhibition as part of the Biotech Week Boston festival.